FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Zoll Medical QSR, MDR Violations

FDA warns Chelmsford, ME-based Zoll Medical about Quality System and Medical Device Reporting violations in its manufacturing of several medical devic...

latest-news-card-1
Biologics

Panel to Weigh Favorable Data on Moderna's mRNA Flu Vaccine

A 6/18 advisory committee meeting is set to review Moderna's investigational mRNA influenza vaccine as the agency posts a briefing document revealing ...

latest-news-card-1

FDA Fails at Providing Risk Management Advice: Post

North Dakota State University economist Raymond March faults the way in which FDA provides risk management guidance to regulated companies.

latest-news-card-1
Human Drugs

Restrict Some Lung Cancer Drugs: Petition

A cancer center precision medicine expert calls on FDA to require labeling changes for some non-small cell lung cancer immune checkpoint inhibitors to...

latest-news-card-1
Human Drugs

FDA Warns Pharmathen Over Sterility, Data Integrity Concerns

FDA sends a Warning Letter to Greek contract manufacturer Pharmathen International citing significant GMP violations at its sterile drug manufacturing...

latest-news-card-1
Human Drugs

FDA Delays Isotretinoin REMS Modifications

FDA says there is an implementation delay for isotretinoin iPLEDGE Risk Evaluation and Mitigation Strategy modifications.

latest-news-card-1
Human Drugs

CGMP Violations Found in Sante Manufacturing Records

FDA warns Canadas Sante Manufacturing about CGMP issues found in an agency review of requested records detailing the firms manufacturing of over-the-c...

latest-news-card-1
Medical Devices

Draeger Anesthesia Workstation Correction Expanded

Draeger expands a 10/2024 device correction (Class 1 recall) to include additional Atlan A350 and A350XL anesthesia workstations used in operating roo...

latest-news-card-1
Human Drugs

Jaypirca Combination Cuts Progression Risk by 45% in CLL Trial: Lilly

Eli Lilly reports positive Phase 3 results for its BTK inhibitor Jaypirca (pirtobrutinib) in combination with venetoclax and rituximab.

latest-news-card-1
Human Drugs

Plausible Mechanism Faces Challenges: Commentary

Significant operational hurdles remain before FDA's Plausible Mechanism Framework can be broadly implemented, according to a commentary published by S...